AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria

Daelyn Y. Richards, Shelley R. Winn, Sandra Dudley, Sean Nygaard, Taylor L. Mighell, Markus Grompe, Cary O. Harding

Open source

DOI
10.1016/j.omtm.2019.12.004
Published
2020-06
Container
Molecular Therapy - Methods & Clinical Development
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtm.2019.12.004,
  title = {AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria},
  author = {Daelyn Y. Richards and Shelley R. Winn and Sandra Dudley and Sean Nygaard and Taylor L. Mighell and Markus Grompe and Cary O. Harding},
  year = {2020},
  journal = {Molecular Therapy - Methods \& Clinical Development},
  doi = {10.1016/j.omtm.2019.12.004},
  url = {https://doi.org/10.1016/j.omtm.2019.12.004}
}

RIS

TY  - JOUR
TI  - AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria
AU  - Daelyn Y. Richards
AU  - Shelley R. Winn
AU  - Sandra Dudley
AU  - Sean Nygaard
AU  - Taylor L. Mighell
AU  - Markus Grompe
AU  - Cary O. Harding
PY  - 2020
JO  - Molecular Therapy - Methods & Clinical Development
DO  - 10.1016/j.omtm.2019.12.004
UR  - https://doi.org/10.1016/j.omtm.2019.12.004
ER  - 

APA

Richards, D. Y., Winn, S. R., Dudley, S., Nygaard, S., Mighell, T. L., Grompe, M., & Harding, C. O. (2020). AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria. Molecular Therapy - Methods & Clinical Development. https://doi.org/10.1016/j.omtm.2019.12.004

Source records